|
Įkelta: 2012-01-24 Peržiūrėjo: 10 Patiko: (TEAR, BLRX, PLCM) CRWENewswire Stocks In ActionBioLineRx Ltd -BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience, to develop and commercialize BL-8020, an orally available treatment for Hepatitis C. KomentaraiPrašome palaukti...
|
Prisijungti su epasas.ltĮkėlė
|
Naujienos





















